BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 23707781)

  • 1. SDH mutations establish a hypermethylator phenotype in paraganglioma.
    Letouzé E; Martinelli C; Loriot C; Burnichon N; Abermil N; Ottolenghi C; Janin M; Menara M; Nguyen AT; Benit P; Buffet A; Marcaillou C; Bertherat J; Amar L; Rustin P; De Reyniès A; Gimenez-Roqueplo AP; Favier J
    Cancer Cell; 2013 Jun; 23(6):739-52. PubMed ID: 23707781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Succinate dehydrogenase is essential for epigenetic and metabolic homeostasis in hearts.
    Li W; Quan L; Peng K; Wang Y; Wang X; Chen Q; Cheng H; Ma Q
    Basic Res Cardiol; 2023 Oct; 118(1):45. PubMed ID: 37819607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
    Castro-Vega LJ; Buffet A; De Cubas AA; Cascón A; Menara M; Khalifa E; Amar L; Azriel S; Bourdeau I; Chabre O; Currás-Freixes M; Franco-Vidal V; Guillaud-Bataille M; Simian C; Morin A; Letón R; Gómez-Graña A; Pollard PJ; Rustin P; Robledo M; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2014 May; 23(9):2440-6. PubMed ID: 24334767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.
    Cascón A; Comino-Méndez I; Currás-Freixes M; de Cubas AA; Contreras L; Richter S; Peitzsch M; Mancikova V; Inglada-Pérez L; Pérez-Barrios A; Calatayud M; Azriel S; Villar-Vicente R; Aller J; Setién F; Moran S; Garcia JF; Río-Machín A; Letón R; Gómez-Graña Á; Apellániz-Ruiz M; Roncador G; Esteller M; Rodríguez-Antona C; Satrústegui J; Eisenhofer G; Urioste M; Robledo M
    J Natl Cancer Inst; 2015 Mar; 107(5):. PubMed ID: 25766404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.
    Morin A; Letouzé E; Gimenez-Roqueplo AP; Favier J
    Int J Cancer; 2014 Nov; 135(10):2237-48. PubMed ID: 25124653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism.
    Lussey-Lepoutre C; Hollinshead KE; Ludwig C; Menara M; Morin A; Castro-Vega LJ; Parker SJ; Janin M; Martinelli C; Ottolenghi C; Metallo C; Gimenez-Roqueplo AP; Favier J; Tennant DA
    Nat Commun; 2015 Nov; 6():8784. PubMed ID: 26522426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis.
    Cardaci S; Zheng L; MacKay G; van den Broek NJ; MacKenzie ED; Nixon C; Stevenson D; Tumanov S; Bulusu V; Kamphorst JJ; Vazquez A; Fleming S; Schiavi F; Kalna G; Blyth K; Strathdee D; Gottlieb E
    Nat Cell Biol; 2015 Oct; 17(10):1317-26. PubMed ID: 26302408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.
    Castro-Vega LJ; Letouzé E; Burnichon N; Buffet A; Disderot PH; Khalifa E; Loriot C; Elarouci N; Morin A; Menara M; Lepoutre-Lussey C; Badoual C; Sibony M; Dousset B; Libé R; Zinzindohoue F; Plouin PF; Bertherat J; Amar L; de Reyniès A; Favier J; Gimenez-Roqueplo AP
    Nat Commun; 2015 Jan; 6():6044. PubMed ID: 25625332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers.
    de Cubas AA; Korpershoek E; Inglada-Pérez L; Letouzé E; Currás-Freixes M; Fernández AF; Comino-Méndez I; Schiavi F; Mancikova V; Eisenhofer G; Mannelli M; Opocher G; Timmers H; Beuschlein F; de Krijger R; Cascon A; Rodríguez-Antona C; Fraga MF; Favier J; Gimenez-Roqueplo AP; Robledo M
    Clin Cancer Res; 2015 Jul; 21(13):3020-30. PubMed ID: 25825477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.
    Dahia PL
    Nat Rev Cancer; 2014 Feb; 14(2):108-19. PubMed ID: 24442145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
    Lenders JW; Duh QY; Eisenhofer G; Gimenez-Roqueplo AP; Grebe SK; Murad MH; Naruse M; Pacak K; Young WF;
    J Clin Endocrinol Metab; 2014 Jun; 99(6):1915-42. PubMed ID: 24893135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline FH mutations presenting with pheochromocytoma.
    Clark GR; Sciacovelli M; Gaude E; Walsh DM; Kirby G; Simpson MA; Trembath RC; Berg JN; Woodward ER; Kinning E; Morrison PJ; Frezza C; Maher ER
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2046-50. PubMed ID: 25004247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor.
    Burford NT; Clark MJ; Wehrman TS; Gerritz SW; Banks M; O'Connell J; Traynor JR; Alt A
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10830-5. PubMed ID: 23754417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force.
    Wolf K; Te Lindert M; Krause M; Alexander S; Te Riet J; Willis AL; Hoffman RM; Figdor CG; Weiss SJ; Friedl P
    J Cell Biol; 2013 Jun; 201(7):1069-84. PubMed ID: 23798731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chemo-enzymatic approach for site-specific modification of the RNA cap.
    Schulz D; Holstein JM; Rentmeister A
    Angew Chem Int Ed Engl; 2013 Jul; 52(30):7874-8. PubMed ID: 23794451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated proteomic analysis of post-translational modifications by serial enrichment.
    Mertins P; Qiao JW; Patel J; Udeshi ND; Clauser KR; Mani DR; Burgess MW; Gillette MA; Jaffe JD; Carr SA
    Nat Methods; 2013 Jul; 10(7):634-7. PubMed ID: 23749302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System-wide analysis reveals intrinsically disordered proteins are prone to ubiquitylation after misfolding stress.
    Ng AH; Fang NN; Comyn SA; Gsponer J; Mayor T
    Mol Cell Proteomics; 2013 Sep; 12(9):2456-67. PubMed ID: 23716602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron microscopy structure of human APC/C(CDH1)-EMI1 reveals multimodal mechanism of E3 ligase shutdown.
    Frye JJ; Brown NG; Petzold G; Watson ER; Grace CR; Nourse A; Jarvis MA; Kriwacki RW; Peters JM; Stark H; Schulman BA
    Nat Struct Mol Biol; 2013 Jul; 20(7):827-35. PubMed ID: 23708605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emi1 preferentially inhibits ubiquitin chain elongation by the anaphase-promoting complex.
    Wang W; Kirschner MW
    Nat Cell Biol; 2013 Jul; 15(7):797-806. PubMed ID: 23708001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.
    Sciacovelli M; Gonçalves E; Johnson TI; Zecchini VR; da Costa AS; Gaude E; Drubbel AV; Theobald SJ; Abbo SR; Tran MG; Rajeeve V; Cardaci S; Foster S; Yun H; Cutillas P; Warren A; Gnanapragasam V; Gottlieb E; Franze K; Huntly B; Maher ER; Maxwell PH; Saez-Rodriguez J; Frezza C
    Nature; 2016 Aug; 537(7621):544-547. PubMed ID: 27580029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.